“…intraperitoneal for 4 weeks; Althunibat et al, 2010). Antioxidant action was found to be mediated via multiple mechanisms, including upregulation of antioxidant enzymes activities, that is, catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione-S-transferase (GST), and (glutathione reductase) GR, concurrent with the reduction of malondialdehyde (MDA) levels (Althunibat et al, 2010) and lipid peroxidation (Al-Gubory et al, 2016) as depicted in Table 1 and Figure Colombo et al, 2013;Cooper et al, 2018;Dey et al, 2015;Howell & D'Souza, 2013;Naseri et al, 2018) Anti-osteoporosis Punicalagin ↑Osteoblastic activity, ↑Calcium deposition ↑ALP, collagen 1a1 and 2a1, BSP, osteocalcin, OPG, DDR2, β-catenin, and LRP5 ↓Osteoclast differentiation ↓Bone resorption ↓NFATc1expression ↓Akt-and JNK dependent pathways ↓Inflammation and oxidative stress (Iwatake et al, 2015;Mélanie Spilmont et al, 2014;Mélanie Spilmont et al, 2015) Effect on lipid metabolism and obesity prevention Ellagic acid, punicalagin, urolithin A, anthocyanins ↓Serum TG, cholesterol, LDL ↓Lipase, FAS ↑LXRα, PPARα, PPARγ, ABCA1 (Wu et al, 2013;Fabroni et al, 2016;Les et al, 2018;Lv et al, 2016;Liu et al, 2015) Antidiabetic Punicalagin, ellagic acid, gallic acid, and valoneic acid dilactone ↓α-Glucosidase, α-amylase, recombinant human maltase-glucoamylase ↑Insulin sensitivity (Al-Muammar & Khan, 2012;Mo et al, 2019;Jain et al, 2012;Kam et al, 2013;Nankar & Doble, 2015) Anti-atherosclerosis Ellagic acid, punicalagin, punicalin, and gallic acid ↓Ox-LDL internalization, foam cell formation, platelet aggregation ↑ABCA1 and LXRα (Hou et al, 2019;Lutz et al, 2019;Park et al, 2011;Zhao et al, 2016) Hepatoprotective Polysaccharides, punicalagin, ellagic acid ↓Liver fibrosis (↓TGF-β1, collagen synthesis) ↑ LXLα ↑ABCA1 ↑PPAR-γ ↑Nrf2-ARE pathway ↓Oxidative stress ↓ Inflammation ↓NFκB pathway ↓Apoptosis ↑Bcl-2…”